BioRem Inc.
BRM.V · TSXV
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CA$0 | CA$0 | CA$0 | CA$0 |
| - Cash | CA$0 | CA$0 | CA$0 | CA$0 |
| + Debt | CA$0 | CA$0 | CA$0 | CA$0 |
| Enterprise Value | CA$0 | CA$0 | CA$0 | CA$0 |
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 19.3% | 99.4% | -49.2% | – |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 28.1% | 27% | 23.5% | 17.1% |
| EBITDA | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 15.5% | 12.3% | 4.8% | 4.6% |
| Net Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 10.3% | 7.9% | 0.8% | 1.8% |
| EPS Diluted | 0.062 | 0.04 | 0.002 | -0.023 |
| % Growth | 55% | 1,900% | 108.5% | – |
| Operating Cash Flow | CA$0 | -CA$0 | CA$0 | -CA$0 |
| Capital Expenditures | CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Free Cash Flow | CA$0 | -CA$0 | CA$0 | -CA$0 |